We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · November 24, 2019

Lenalidomide Maintenance for DLBCL Responding to R-CHOP

British Journal of Haematology

 

Additional Info

British Journal of Haematology
Lenalidomide Maintenance for Diffuse Large B-Cell Lymphoma Patients Responding to R-CHOP: Quality of Life, Dosing, and Safety Results From the Randomised Controlled REMARC Study
Br. J. Haematol 2019 Nov 08;[EPub Ahead of Print], C Thieblemont, S Howlett, RO Casasnovas, N Mounier, A Perrot, F Morschhauser, C Fruchart, N Daguindau, K van Eygen, L Obéric, R Bouabdallah, GM Pica, E Nicolas-Virezelier, J Abraham, O Fitoussi, S Snauwaert, JC Eisenmann, P Lionne-Huyghe, D Bron, S Tricot, D Deeren, H Gonzalez, R Costello, K Le Du, MG da Silva, S Grosicki, J Trotman, J Catalano, D Caballero, R Greil, AM Cohen, P Gaulard, L Roulin, K Takeshita, ML Casadebaig, H Tilly, B Coiffier

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading